Abnormal myocardial perfusion and risk of heart failure in patients with type 2 diabetes mellitus - PubMed (original) (raw)
. 2013 Winter;18(1):e44-6.
Affiliations
- PMID: 24294048
- PMCID: PMC3716502
Abnormal myocardial perfusion and risk of heart failure in patients with type 2 diabetes mellitus
Marcelo Utrera-Lagunas et al. Exp Clin Cardiol. 2013 Winter.
Abstract
Background: Diabetes is a major risk factor for heart failure (HF), although the pathophysiological processes have not been clarified.
Objective: To determine the prevalence of HF and of abnormal myocardial perfusion in diabetic patients evaluated using technetium (99m) sestamibi single-photon emission computed tomography.
Methods: An observational cross-sectional study was conducted that included patients with type 2 diabetes mellitus who underwent echocardiography to diagnose HF and a pharmacological stress test with intravenous dipyridamole to examine cardiac scintigraphic perfusion abnormalities. Clinical and biochemical data were also collected.
Results: Of the 160 diabetic patients included, 92 (57.6%) were in HF and 68 (42.5%) were not. When patients were stratified according to the presence of abnormal myocardial perfusion, those with abnormal perfusion had a higher prevalence of HF (93%) than those with normal perfusion (44.4%) (P<0.0001). Patients with HF weighed more (P=0.03), used insulin less frequently (P=0.01), had lower total cholesterol (P=0.05) and high-density lipoprotein cholesterol concentrations (P=0.002), and a greater number of their myocardial segments showed abnormal perfusion (P≤0.001). More HF patients had a history of myocardial infarction (P<0.001) compared with those without HF. In a logistic regression analysis, the number of segments exhibiting abnormal myocardial perfusion was an independent risk factor for HF.
Conclusions: The prevalence of HF in diabetic patients was high and HF predominantly occured in association with myocardial ischemia.
Keywords: Diabetes mellitus; Heart failure; Myocardial perfusion.
Similar articles
- Prevalence and predictors of an abnormal stress myocardial perfusion study in asymptomatic patients with type 2 diabetes mellitus.
Scholte AJ, Schuijf JD, Kharagjitsingh AV, Dibbets-Schneider P, Stokkel MP, van der Wall EE, Bax JJ. Scholte AJ, et al. Eur J Nucl Med Mol Imaging. 2009 Apr;36(4):567-75. doi: 10.1007/s00259-008-0967-y. Epub 2008 Nov 5. Eur J Nucl Med Mol Imaging. 2009. PMID: 18985347 - Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus.
Sella EM, Sato EI, Leite WA, Oliveira Filho JA, Barbieri A. Sella EM, et al. Ann Rheum Dis. 2003 Nov;62(11):1066-70. doi: 10.1136/ard.62.11.1066. Ann Rheum Dis. 2003. PMID: 14583569 Free PMC article. - Myocardial perfusion imaging in diabetes mellitus.
Freeman M. Freeman M. Can J Cardiol. 2006 Feb;22 Suppl A:22A-25A. doi: 10.1016/s0828-282x(06)70975-8. Can J Cardiol. 2006. PMID: 16485056 Review.
Cited by
- Epidemiology of heart failure in diabetes: a disease in disguise.
Hoek AG, Dal Canto E, Wenker E, Bindraban N, Handoko ML, Elders PJM, Beulens JWJ. Hoek AG, et al. Diabetologia. 2024 Apr;67(4):574-601. doi: 10.1007/s00125-023-06068-2. Epub 2024 Feb 9. Diabetologia. 2024. PMID: 38334818 Free PMC article. Review. - Noninvasive Cardiac Imaging in Formerly Preeclamptic Women for Early Detection of Subclinical Myocardial Abnormalities: A 2022 Update.
Brandt Y, Ghossein-Doha C, Gerretsen SC, Spaanderman MEA, Kooi ME. Brandt Y, et al. Biomolecules. 2022 Mar 7;12(3):415. doi: 10.3390/biom12030415. Biomolecules. 2022. PMID: 35327607 Free PMC article. Review. - The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis.
Bouthoorn S, Valstar GB, Gohar A, den Ruijter HM, Reitsma HB, Hoes AW, Rutten FH. Bouthoorn S, et al. Diab Vasc Dis Res. 2018 Nov;15(6):477-493. doi: 10.1177/1479164118787415. Epub 2018 Jul 24. Diab Vasc Dis Res. 2018. PMID: 30037278 Free PMC article. - Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017.
Einarson TR, Acs A, Ludwig C, Panton UH. Einarson TR, et al. Cardiovasc Diabetol. 2018 Jun 8;17(1):83. doi: 10.1186/s12933-018-0728-6. Cardiovasc Diabetol. 2018. PMID: 29884191 Free PMC article. - Insulin and β Adrenergic Receptor Signaling: Crosstalk in Heart.
Fu Q, Wang Q, Xiang YK. Fu Q, et al. Trends Endocrinol Metab. 2017 Jun;28(6):416-427. doi: 10.1016/j.tem.2017.02.002. Epub 2017 Feb 28. Trends Endocrinol Metab. 2017. PMID: 28256297 Free PMC article. Review.
References
- Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal Diabetes control in type 2 diabetic patients. Diabetes Care. 2000;23(Suppl 2):B21–B29. - PubMed
- Leung AA, Eurich DT, Lamb DA, et al. Risk of HF in patients with recent-onset type 2 diabetes: Population-based cohort study. J Cardiac Fail. 2009;15:152–7. - PubMed
- MacDonald MR, Petrie MC, Hawkins NM, et al. Diabetes, left ventricular systolic dysfunction, and chronic HF. Eur Heart J. 2008;29:1224–40. - PubMed
- Bertoni G, Hundley G, Massing M, Bonds D, Burke G, Goff D. HF prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care. 2004;27:699–703. - PubMed
- Nichols GA, Hillier TA, Erbey JR, Brown JB. Congestive HF in type 2 diabetes: Prevalence, incidence, and risk factors. Diabetes Care. 2001;24:1614–9. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous